You are viewing the site in preview mode

Skip to main content

Table 3 Laboratory Data

From: Impact of diabetes mellitus on the early-phase arterial healing after drug-eluting stent implantation

  DM (n = 149) Non-DM (n = 188) p value
At the time of PCI
 HbA1c, % 7.1 ± 1.2 5.8 ± 0.5 < 0.001
 FBS, mg/dL 156 ± 60 110 ± 30 < 0.001
 Total cholesterol, mg/dL 176 ± 39 180 ± 38 0.25
 Triglyceride, mg/dL 169 ± 109 133 ± 100 0.002
 HDL-cholesterol, mg/dL 44 ± 13 50 ± 14 < 0.001
 LDL-cholesterol, mg/dL 103 ± 32 105 ± 34 0.58
 CRP, mg/dL 0.42 ± 1.04 0.71 ± 2.53 0.17
 Hemoglobin, g/dL 13.5 ± 2.1 13.7 ± 1.7 0.45
 Creatinine, mg/dL 1.2 ± 1.9 1.1 ± 1.1 0.31
 eGFR, mL/min/m2 65 ± 21 64 ± 18 0.39
 Uric acid, mg/dL 5.6 ± 1.5 5.9 ± 1.5 0.052
At the time of CAS evaluation
 HbA1c, % 6.8 ± 0.8 5.7 ± 0.5 < 0.001
 FBS, mg/dL 146 ± 55 107 ± 21 < 0.001
 Total cholesterol, mg/dL 162 ± 35 170 ± 31 0.036
 Triglyceride, mg/dL 151 ± 112 141 ± 100 0.36
 HDL-cholesterol, mg/dL 47 ± 18 50 ± 13 0.057
 LDL-cholesterol, mg/dL 90 ± 26 92 ± 25 0.46
 CRP, mg/dL 0.24 ± 0.52 0.32 ± 1.25 0.49
 Hemoglobin, g/dL 13.2 ± 1.9 13.6 ± 1.6 0.036
 Creatinine, mg/dL 1.5 ± 3.8 1.1 ± 0.9 0.19
 eGFR, mL/min/m2 64 ± 18 60 ± 17 0.14
 Uric acid, mg/dL 5.6 ± 1.5 5.9 ± 1.5 0.073
  1. Data are presented as mean ± SD
  2. CAS  coronary angiography, CRP   C-reactive protein, DM diabetes mellitus, eGFR  estimated glomerular filtration rate, FBS fasting blood sugar, HbA1c  Hemoglobin A1c, HDL high-density lipoprotein, LDL  low-density lipoprotein